Since chromosome aberration has shown to be strongly correlated with mRNA dysregulation in cancer development37, we therefore investigate the oncogenomic database of HCC patients (OncoDB.HCC), indicating that chromosome 7q36.1, where EZH2 located, gain/amplification is prevalent in four CGH studies. This evidence concerns the gene EZH2 and hepatocellular carcinoma.